104 related articles for article (PubMed ID: 38742767)
1. Perivascular NOTCH3+ stem cells drive meningioma tumorigenesis and resistance to radiotherapy.
Choudhury A; Cady MA; Lucas CG; Najem H; Phillips JJ; Palikuqi B; Zakimi N; Joseph T; Birrueta JO; Chen WC; Oberheim Bush NA; Hervey-Jumper SL; Klein OD; Toedebusch CM; Horbinski CM; Magill ST; Bhaduri A; Perry A; Dickinson PJ; Heimberger AB; Ashworth A; Crouch EE; Raleigh DR
Cancer Discov; 2024 May; ():. PubMed ID: 38742767
[TBL] [Abstract][Full Text] [Related]
2. NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.
Choudhury A; Cady MA; Lucas CG; Najem H; Phillips JJ; Palikuqi B; Zakimi N; Joseph T; Birrueta JO; Chen WC; Bush NAO; Hervey-Jumper SL; Klein OD; Toedebusch CM; Horbinski CM; Magill ST; Bhaduri A; Perry A; Dickinson PJ; Heimberger AB; Ashworth A; Crouch EE; Raleigh DR
bioRxiv; 2023 Jul; ():. PubMed ID: 37503127
[TBL] [Abstract][Full Text] [Related]
3. Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.
Lucas CH; Mirchia K; Seo K; Najem H; Chen W; Zakimi N; Choudhury A; Liu SJ; Phillips J; Magill S; Horbinski C; Solomon D; Perry A; Vasudevan H; Heimberger A; Raleigh D
Res Sq; 2023 May; ():. PubMed ID: 37292686
[TBL] [Abstract][Full Text] [Related]
4. Merlin
Eaton C; Avalos L; Liu SJ; Casey-Clyde T; Bisignano P; Lucas CH; Stevenson E; Choudhury A; Vasudevan H; Magill S; Krogan N; Villanueva-Meyer J; Swaney D; Raleigh D
Res Sq; 2023 Mar; ():. PubMed ID: 36993679
[TBL] [Abstract][Full Text] [Related]
5. Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution.
Lucas CG; Mirchia K; Seo K; Najem H; Chen WC; Zakimi N; Foster K; Eaton CD; Cady MA; Choudhury A; Liu SJ; Phillips JJ; Magill ST; Horbinski CM; Solomon DA; Perry A; Vasudevan HN; Heimberger AB; Raleigh DR
Nat Genet; 2024 May; ():. PubMed ID: 38760638
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
7. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of tumor stem-like cells from human meningiomas.
Hueng DY; Sytwu HK; Huang SM; Chang C; Ma HI
J Neurooncol; 2011 Aug; 104(1):45-53. PubMed ID: 21116836
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
Sá-Marta E; Alves JL; Rebelo O; Barbosa M
World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
[TBL] [Abstract][Full Text] [Related]
10. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
Choudhury A; Magill ST; Eaton CD; Prager BC; Chen WC; Cady MA; Seo K; Lucas CG; Casey-Clyde TJ; Vasudevan HN; Liu SJ; Villanueva-Meyer JE; Lam TC; Pu JK; Li LF; Leung GK; Swaney DL; Zhang MY; Chan JW; Qiu Z; Martin MV; Susko MS; Braunstein SE; Bush NAO; Schulte JD; Butowski N; Sneed PK; Berger MS; Krogan NJ; Perry A; Phillips JJ; Solomon DA; Costello JF; McDermott MW; Rich JN; Raleigh DR
Nat Genet; 2022 May; 54(5):649-659. PubMed ID: 35534562
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
13. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma.
Samarut E; Lugat A; Amelot A; Scharbarg E; Hadjadj S; Primot C; Loussouarn D; Thillays F; Buffenoir K; Cariou B; Drui D; Roualdes V
J Neurooncol; 2021 Mar; 152(1):115-123. PubMed ID: 33392938
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 and vascular endothelial growth factor expression in intracranial meningiomas in dogs.
Matiasek LA; Platt SR; Adams V; Scase TJ; Keys D; Miller J; Adamo F; Long S; Matiasek K
J Vet Intern Med; 2009; 23(1):146-51. PubMed ID: 19175733
[TBL] [Abstract][Full Text] [Related]
15. Animal models of meningiomas.
Mawrin C
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S6. PubMed ID: 28595424
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?
Marcus HJ; Price SJ; Wilby M; Santarius T; Kirollos RW
Br J Neurosurg; 2008 Aug; 22(4):520-8. PubMed ID: 18803079
[TBL] [Abstract][Full Text] [Related]
17. Meningioma: current updates on genetics, classification, and mouse modeling.
Szulzewsky F; Thirimanne HN; Holland EC
Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
[TBL] [Abstract][Full Text] [Related]
18. Meningioma mouse models.
Kalamarides M; Peyre M; Giovannini M
J Neurooncol; 2010 Sep; 99(3):325-31. PubMed ID: 20734219
[TBL] [Abstract][Full Text] [Related]
19. Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas.
Maggio I; Franceschi E; Tosoni A; Nunno VD; Gatto L; Lodi R; Brandes AA
CNS Oncol; 2021 Jun; 10(2):CNS72. PubMed ID: 34015955
[TBL] [Abstract][Full Text] [Related]
20. Meningioma: Signaling pathways and tumor growth.
Burnett BA; Womeldorff MR; Jensen R
Handb Clin Neurol; 2020; 169():137-150. PubMed ID: 32553285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
